MCIDAS and glaucoma: Studies in both human patients and animal models have revealed mitochondrial abnormalities in glaucoma, including oxidative stress, ATP depletion, and deficiencies in mitochondrial complex I (MCI).12–14 These findings underscore the potential of targeting mitochondrial function as a novel therapeutic strategy for glaucoma.